Literature DB >> 36238541

Operator's Influence on Contrast Agent Intravasation During Hysterosalpingo-Contrast Sonography: Explanation Based on a Physics Model.

Bin-Bin Jin1, Yan Ma1, Xiu-Hua Zhao1, Yi-Ling Teng1, Shang-Yong Zhu1.   

Abstract

Objective: To analyze the risk factors of the operators on contrast agent intravasation during hysterosalpingo-contrast sonography (HyCoSy).
Methods: We retrospectively collected 399 infertile women who underwent HyCoSy by the same sonographer. These patients were divided into two groups according to the way how the assistants connected the syringe to the uterus radiography catheter to inject the contrast agent. We analyzed whether the use of different contrast bolus injection methods had any influence on the incidence of intravasation during HyCoSy.
Results: There was no significant difference between the two groups with different cross-sectional areas of the syringe outflow tract in the risk variables for intravasation, but the intravasation rates of the two groups were different, 26.4% in group A and 17.1% in group B, P <0.05. The primary manifestation was that when both fallopian tubes were unobstructed, the intravasation rate of group B with smaller cross-sectional area of the outflow tract of the syringe was lower, and the difference was statistically significant. The inferences drawn from our physics model were also in line with the clinical results.
Conclusion: The influence of different operators on the contrast agent intravasation rate of HyCoSy cannot be ignored. The assistants of HyCoSy examination should inject the contrast agent slowly and steady, and a needle can be used as a flow restrictor to control the flow into the uterine cavity per unit time, slow down the rising speed of intrauterine pressure, and avoid the accumulation of contrast agent in the uterine cavity, so as to reduce the intravasation caused by operator factors.
© 2022 Jin et al.

Entities:  

Keywords:  contrast agent; fallopian tube patency; hysterosalpingo-contrast sonography; infertility; intravasation; ultrasonography

Year:  2022        PMID: 36238541      PMCID: PMC9552795          DOI: 10.2147/IJGM.S380917

Source DB:  PubMed          Journal:  Int J Gen Med        ISSN: 1178-7074


  14 in total

1.  Infertility Workup for the Women's Health Specialist: ACOG Committee Opinion, Number 781.

Authors: 
Journal:  Obstet Gynecol       Date:  2019-06       Impact factor: 7.661

2.  Diagnostic efficacy of 3-D hysterosalpingo-contrast sonography in the detection of tubal occlusion: Systematic meta-analysis.

Authors:  Jiangxiu Yu; Mingjin Cai; Weixiang Liang; Zhifeng Deng; Yinong Xie
Journal:  J Obstet Gynaecol Res       Date:  2015-06-22       Impact factor: 1.730

3.  First experience using 4-dimensional hysterosalpingo-contrast sonography with SonoVue for assessing fallopian tube patency.

Authors:  Yanni He; Qiang Geng; Hongmei Liu; Xiaohua Han
Journal:  J Ultrasound Med       Date:  2013-07       Impact factor: 2.153

Review 4.  Three- or four-dimensional hysterosalpingo contrast sonography for diagnosing tubal patency in infertile females: a systematic review with meta-analysis.

Authors:  Yuelong Wang; Linxue Qian
Journal:  Br J Radiol       Date:  2016-04-25       Impact factor: 3.039

5.  The Influencing Factors of Venous Intravasation During Transvaginal Four-dimensional Hysterosalpingo-contrast Sonography With SonoVue.

Authors:  Jiayao Shi; Sushu Li; Haorong Wu; Yanni He; Wenhong Yi; Jingjiao Xu; Hongmei Liu; Ying Guan
Journal:  Ultrasound Med Biol       Date:  2019-06-11       Impact factor: 2.998

6.  Causes of misdiagnosis in assessing tubal patency by transvaginal real-time three-dimensional hysterosalpingo-contrast sonography.

Authors:  Na Liang; Qing-Qing Wu; Jing-Hua Li; Feng-Yun Gao; Fu-Li Sun; Cui-Xia Guo
Journal:  Rev Assoc Med Bras (1992)       Date:  2019-09-12       Impact factor: 1.209

7.  Pain and side effects associated with 4-dimensional hysterosalpingo-contrast sonography for evaluating of the fallopian tubes patency.

Authors:  Hongbo Li; MeiMei Zhang; Ye Qiang; YunFei Ma; ShuXia Mao; Hao Zhang
Journal:  Comput Assist Surg (Abingdon)       Date:  2017-09-22       Impact factor: 1.787

8.  Two-dimensional HyCoSy with contrast tuned imaging technology and a second-generation contrast media for the assessment of tubal patency in an infertility program.

Authors:  Chiara Lanzani; Valeria Savasi; Francesco P G Leone; Martina Ratti; Enrico Ferrazzi
Journal:  Fertil Steril       Date:  2008-10-01       Impact factor: 7.329

9.  Combined Real-Time Three-Dimensional Hysterosalpingo-Contrast Sonography with B Mode Hysterosalpingo-Contrast Sonography in the Evaluation of Fallopian Tube Patency in Patients Undergoing Infertility Investigations.

Authors:  Sumin Chen; Xiya Du; Qingzi Chen; Shaoqi Chen
Journal:  Biomed Res Int       Date:  2019-06-03       Impact factor: 3.411

10.  Adverse reactions after the use of SonoVue contrast agent: Characteristics and nursing care experience.

Authors:  Chenlu Hu; Yinger Feng; Pintong Huang; Jingfen Jin
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.